Kaiser Daily Health Policy Report Highlights News Coverage Of Prospects For FDA, Rule Changes On Health Care Issues In New Administration
Main Category: Regulatory Affairs / Drug ApprovalsAlso Included In: Smoking / Quit Smoking; Public Health; Health Insurance / Medical Insurance
Article Date: 10 Nov 2008 - 0:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Summaries of several recent developments related to prospects for FDA and rule changes on health care issues in the new administration of President-elect Barack Obama appear below.
- FDA: Obama could seek to increase FDA oversight of imported foods and medications and expand the authority of the agency to regulate additional products, such as tobacco, the AP/Miami Herald reports. Obama campaign adviser Neera Tanden said that he will make food safety a priority for FDA. According to AP/Herald, Obama "is being urged to move quickly to appoint a FDA commissioner," and some possibilities include Cleveland Clinic cardiologist Steven Nissen; Susan Wood, former director of FDA's Office of Women's Health; and Baltimore Health Commissioner Joshua Sharfstein (Alonso-Zaldivar, AP/Miami Herald, 11/6). Nissen and Sharfstein "are among candidates being backed by consumer advocacy groups critical of the agency," and FDA Center for Drug Evaluation and Research Director Janet Woodcock, a fourth possibility for agency commissioner, "is the top choice of drugmakers," Bloomberg reports (Blum, Bloomberg, 11/7).
- Rule changes: Congressional Democrats and their health care advisers have begun to prepare a list of executive orders, rules and regulations issued by the Bush administration that they hope Obama will overturn after he takes office, the Washington Post's "44" reports. According to the Post's "44," the "most obvious target is lifting federal restrictions on embryonic stem cell research." Congressional Democrats also hope to overturn a policy directive issued last year by HHS that limits the ability of states to expand their SCHIP programs (Connolly, "44," Washington Post, 11/6).
Opinion Pieces
Summaries of several recent opinion pieces that addressed health care issues in the Obama administration appear below.
- Paul Krugman, New York Times: "Right now, many commentators are urging Mr. Obama to think small" on his agenda in part because they maintain that the "financial and economic crisis leaves no room for action on, say, health care reform," but Obama should have the "good sense to ignore this advice," Times columnist Krugman writes. According to Krugman, "standard textbook economics says that it's OK, in fact appropriate, to run temporary deficits in the face of a depressed economy," and "one or two years of red ink, while it would add modestly to future federal interest expenses, shouldn't stand in the way of a health care plan that, even if quickly enacted into law, probably wouldn't take effect until 2011." He adds, "Helping the neediest in a time of crisis, through expanded health and unemployment benefits, is the morally right thing to do; it's also a far more effective form of economic stimulus than cutting the capital gains tax." A "serious progressive agenda -- call it a new New Deal -- isn't just economically possible, it's exactly what the economy needs," Krugman writes, adding, "The bottom line, then, is that Barack Obama shouldn't listen to the people trying to scare him into being a do-nothing president" (Krugman, New York Times, 11/7).
- Former Sen. Rick Santorum (R-Pa.), Philadelphia Inquirer: The question of whether Obama will "be led to the left by Congress" on health care and other issues or "will ... lead in a more moderate direction" remains unanswered, Santorum writes in an Inquirer opinion piece. Santorum writes, "If he is led, our economy will struggle under greater taxes on investors and higher-income workers," federal "domestic spending would explode" and employees of "small businesses would get Medicaid-like government health insurance, paid for by taxing their employers." In addition, if Obama is led by Congress, he would "require businesses to provide paid family medical leave," and embryonic stem cell research would "get federal funding, as would cloning of human beings for research purposes," Santorum writes (Santorum, Philadelphia Inquirer, 11/6).
- Bret Swanson, Wall Street Journal: "If Barack Obama ran for president by calling for a heavier hand of government, he also won by running one of the most entrepreneurial campaigns in history," but questions remain about whether Obama will "come to see that unleashing the entrepreneur is the best way to raise the revenue he needs for his lofty priorities," such as health care, Swanson, a senior fellow and director of the Center for Global Innovation at the Progress & Freedom Foundation, writes in a Journal opinion piece. He writes, "We are not going to 'solve' the entitlements crisis by gouging American producers to pay for the current Medicare/Medicaid abomination," adding, "Much better to transcend the issue with medical innovations and an entrepreneurial, consumer-driven market where more physicians go into medical technology, more nurses replace doctors, more technologies replace doctor visits, and with properly-aligned incentives and real prices, more citizens take better care of their own health and thus their pocket books." According to Swanson, the "only way to escape current predictions of scarcity is the unforeseen abundance that entrepreneurship can bring" (Swanson, Wall Street Journal, 11/7).
Broadcast Coverage
NPR's "Morning Edition" on Thursday examined the prospects for the health care and other industries under the Obama administration. The segment includes comments from Les Funtleyder, a health care strategist for Miller Tabak, and Bruce Josten, chief lobbyist for the U.S. Chamber of Commerce (Keith, "Morning Edition," NPR, 11/6).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.
© 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our regulatory affairs / drug approvals section for the latest news on this subject.
MLA
3 Feb. 2012. <http://www.medicalnewstoday.com/releases/128669.php>
APA
http://www.medicalnewstoday.com/releases/128669.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



